Lorlatinib 100 mg | Lorlatinib price| Lorlatinib side effects

Lorbrexen 100 mg (Lorlatinib) is a strong, brain-penetrating drug that targets ALK and ROS1 proteins. It covers many ALK mutations. In early studies, it showed effectiveness in patients with ALK-positive non-small-cell lung cancer, especially those with brain metastases and who had not improved after other ALK treatments.